Jeffrey Guss und Nyu - Info zur Person

(1 - 19 von 20

)

NYU Professors at Horizons Conference Share Psychedelic Research |...

nyunews.com

Three NYU Professors shared mind-altering information at Cooper Union last weekend during the annual Horizons Conference — a forum that discusses the use of...

Single Dose of Hallucinogenic Drug Psilocybin Relieves Anxiety &...

nyulangone.org

NYU Langone study finds the hallucinogenic drug psilocybin, when combined with counseling, relieves depression and anxiety in cancer patients. Learn more.

Single dose of hallucinogenic | EurekAlert! Science News Releaseswww.eurekalert.org › pub_releases › nlmc-sdo

www.eurekalert.org

· Study co-investigator Jeffrey Guss, MD, a clinical assistant professor of psychiatry at NYU Langone, notes that psilocybin has been studied ...

Facebook: Dr. Jeffrey Guss: NYU Psilocybin for Psychedelic Education and ...

Facebook: NYU Psilocybin Cancer Anxiety Study - Dr. Jeffrey Gusswww.facebook.com › events › nyu...

Verändere dein Bewusstsein: Was uns die neue Psychedelik-Forschung ...books.google.de › books

books.google.de

Jeffrey Guss, Psychiater in Manhattan und an dem Versuch an der NYU beteiligt, glaubt, die Zeit könnte dafür reif sein, dass die Psychotherapie ein völlig ...

Programmebooklet_WEB_v SlideSharede.slideshare.net › ChristalGadiot › programmebook...

de.slideshare.net

... Poster Presentations ~ Jeffrey Guss The NYU School of Medicine Albert Dahan ~ Jeffrey Guss & Elizabeth Nielson Ketamine, ...

REBT- CBT Forum - Yahoo Groups

groups.yahoo.com

The NYU Training Program for Psychedelic Psychotherapy Jeffrey Guss, MD Abstract: In 2008, the NYU Psilocybin Cancer Anxiety Research ...

Jeffrey Guss – ICPR 2020icpr2020.net › speakers › jeffrey-guss

icpr2020.net

He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine's study on psilocybin-assisted psychotherapy in the ...

Board Member | ISSP - International Society for Substance â€¦

is-sp.org

Prof. Jeffrey Guss, MD Jeffrey is Assistant Professor of Psychiatry at New York University, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicineâ€™s study on ...

Onkologen auf dem Trip - DocCheck

www.doccheck.com

Die Studienautoren Anthony Bossis (links), Stephen Ross (Mitte) und Jeffrey Guss (rechts). Quelle: NYU Langone Medical Center. Das Ergebnis. Beide Forschergruppe berichten von einem ähnlichen Behandlungserfolg. Bei etwa 80 Prozent der Teilnehmer hatte sich â€“ auch sechs Monaten nach der Psilocybin-Einnahme â€“ Depression und Angststörung ...

Jeffrey R. Guss - NYU Langone Healthmed.nyu.edu › faculty › jeffrey-r-guss

med.nyu.edu

Jeffrey R. Guss, MD. Clinical Assistant Professor, Department of Psychiatry. Positions & Education; Publications ...

2011 Einstein Student-run Social Medicine Course at ALAMES: Latin...

www.socialmedicine.org

Dr. Jeffrey Guss NYU Psilocybin Cancer Anxiety Research Project : Wednesday, 5:30-6:30. Dr. Rohit Bhalla Patient Protection and ...

Behavioral Health Brief: Psychedelic Help - Social Work Todaywww.socialworktoday.com › archive

www.socialworktoday.com

"Anxiety and depression improved significantly—and this lasted for up to eight months," explains Jeffrey Guss, MD, coprincipal investigator on the NYU study.

Psilocybin Cancer Anxiety Study - Full Text View - ClinicalTrials.gov

clinicaltrials.gov

... Investigator NYU Langone School of Medicine. Study Director: Jeffrey Guss, MD, Co-Principal Investigator NYU Langone School of Medicine ...

The NYU Training Program for Psychedelic Psychotherapy

2013.psychedelicscience.org

Jeffrey Guss, MD is a Clinical Assistant Professor of Psychiatry at the New York University School of Medicine. He is Co-Principal Investigator and Director of ...